A whole new way to look at clinical design and portfolio optimization
October 13, 2009, 12:00 - 1:00 p.m.
Webcast
webcast,
Details
Register for Recaps free, live webinar on October 13th.
Get a sneak peak at Recaps new clinical development business intelligence tool and discover a whole new way to look at clinical design and portfolio optimization:
Glean insights into trends on drug advancement and termination decisions by therapeutic class and trial design. Our analysis goes beyond percentages to the reasons behind project and compound advancement or termination. Understand how fast successful companies have gotten their drugs approved.
Examine how efficiently companies have made key "go/no-go" drug development decisions.
Who should attend: *R&D executives *Chief Scientific Officers *CEOs *CFOs *Business Development
